Business Description
Redcare Pharmacy NV
ISIN : NL0012044747
Compare
Compare
Traded in other countries / regions
RDC.Germany0RJT.UKSHPPF.USASHOP.Austria IPO Date
2018-05-07Description
Redcare Pharmacy NV operates an online pharmacy store. Its product portfolio is focused on prescription medications, over-the-counter medications, and pharmacy-related beauty and personal care products. The company's operating segment includes DACH and International. It generates maximum revenue domestically from the DACH segment. Geographically, it has a presence in Germany, Austria, Switzerland, Netherlands, Belgium, Spain, France, and Italy.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.86 | |||||
| Equity-to-Asset | 0.5 | |||||
| Debt-to-Equity | 0.48 | |||||
| Debt-to-EBITDA | 5.03 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 6.36 | |||||
| Beneish M-Score | -2.83 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 11.6 | |||||
| 3-Year EBITDA Growth Rate | 51.8 | |||||
| 3-Year EPS without NRI Growth Rate | -3.7 | |||||
| 3-Year Book Growth Rate | 3.5 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 24.99 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 30.56 | |||||
| 9-Day RSI | 42.64 | |||||
| 14-Day RSI | 47.99 | |||||
| 3-1 Month Momentum % | 33.83 | |||||
| 6-1 Month Momentum % | 42.98 | |||||
| 12-1 Month Momentum % | 23.72 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.12 | |||||
| Quick Ratio | 1.53 | |||||
| Cash Ratio | 0.86 | |||||
| Days Inventory | 28.81 | |||||
| Days Sales Outstanding | 17.73 | |||||
| Days Payable | 35.53 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.5 | |||||
| Shareholder Yield % | 0.19 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 23.2 | |||||
| Operating Margin % | -0.96 | |||||
| Net Margin % | -1.1 | |||||
| FCF Margin % | -0.47 | |||||
| ROE % | -4.76 | |||||
| ROA % | -2.37 | |||||
| ROIC % | -3.01 | |||||
| 3-Year ROIIC % | -4.66 | |||||
| ROC (Joel Greenblatt) % | -13.86 | |||||
| ROCE % | -2.57 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 895.83 | |||||
| PS Ratio | 1.33 | |||||
| PB Ratio | 5.89 | |||||
| Price-to-Tangible-Book | 33.08 | |||||
| Price-to-Operating-Cash-Flow | 96.13 | |||||
| EV-to-EBIT | -149.67 | |||||
| EV-to-Forward-EBIT | 118.22 | |||||
| EV-to-EBITDA | 63.58 | |||||
| EV-to-Forward-EBITDA | 39.47 | |||||
| EV-to-Revenue | 1.39 | |||||
| EV-to-Forward-Revenue | 1.06 | |||||
| EV-to-FCF | -303.41 | |||||
| Price-to-GF-Value | 0.93 | |||||
| Price-to-Projected-FCF | 139.35 | |||||
| Price-to-Net-Current-Asset-Value | 1254.17 | |||||
| Earnings Yield (Greenblatt) % | -0.67 | |||||
| FCF Yield % | -0.33 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Redcare Pharmacy NV Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 2,226.756 | ||
| EPS (TTM) (€) | -1.232 | ||
| Beta | 1.09 | ||
| 3-Year Sharpe Ratio | 0.2 | ||
| 3-Year Sortino Ratio | 0.28 | ||
| Volatility % | 34.4 | ||
| 14-Day RSI | 47.99 | ||
| 14-Day ATR (€) | 3.661331 | ||
| 20-Day SMA (€) | 150.995 | ||
| 12-1 Month Momentum % | 23.72 | ||
| 52-Week Range (€) | 97.5 - 171.2 | ||
| Shares Outstanding (Mil) | 20.02 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Redcare Pharmacy NV Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Redcare Pharmacy NV Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Redcare Pharmacy NV Frequently Asked Questions
What is Redcare Pharmacy NV(WBO:SHOP)'s stock price today?
The current price of WBO:SHOP is €150.50. The 52 week high of WBO:SHOP is €171.20 and 52 week low is €97.50.
When is next earnings date of Redcare Pharmacy NV(WBO:SHOP)?
The next earnings date of Redcare Pharmacy NV(WBO:SHOP) is .
Does Redcare Pharmacy NV(WBO:SHOP) pay dividends? If so, how much?
Redcare Pharmacy NV(WBO:SHOP) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers